Intervention
DNA analysis
ClinicalTrials.gov intervention label
Explore related research
Search across original and mapped recordsSearch results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov intervention label, found in 25 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
25 shownThe Role of Genetic Factors in the Development of Breast Cancer in the Kazakh PopulationNCT05090605 · 2022-03-30
COMPLETEDProgram for the Introduction Into Clinical Practice of the Principles of Personalized and Preventive Medicine Based on the Isolation of Gene Polymorphism in Schizophrenia in People of the Kazakh Ethnic GroupNCT05090644 · 2022-03-30
COMPLETEDThe Role of Genetic Factors in the Development of Arterial Hypertension in the Kazakh PopulationNCT05088486 · 2022-03-30
COMPLETEDCollecting and Studying Tissue Samples From Patients With HIV-Associated MalignanciesNCT01567722 · 2013-01-02
TERMINATEDStudy of Tissue Samples From Patients With Non-Small Cell Lung CancerNCT01414595 · 2012-03-01
COMPLETEDStudying Blood and DNA Samples From Patients With Breast Cancer Treated With Chemotherapy With or Without TrastuzumabNCT01562288 · 2012-02-01
COMPLETEDGenetic Susceptibility to Radiation-Induced Skin Reactions in Racial/Ethnic Groups of Patients With Breast CancerNCT01407770 · 2011-09-20
COMPLETEDBiomarkers in Blood Samples From Patients With HIV Infection and Stage III or Stage IV Hodgkin Lymphoma Undergoing ChemotherapyNCT01319526 · 2011-06-01
TERMINATEDBiomarkers in Tissue Samples From Patients With Breast Cancer Treated With BevacizumabNCT01156168 · 2011-04-05
COMPLETEDBiomarkers in Blood Samples From Patients With Refractory Non-Small Cell Lung Cancer Previously Treated With Sorafenib TosylateNCT01124669 · 2010-06-13
COMPLETEDVaccine Therapy in Preventing HPV in HIV-Positive Women in IndiaNCT00667563 · 2009-08-01
COMPLETEDHuman Papilloma Virus Infection in HIV-Positive Indian Men Who Have Sex With MenNCT00919997 · 2009-07-01
COMPLETEDStudy of Blood Samples From High-Risk Postmenopausal Women Who Received Treatment on Breast Cancer Prevention Clinical Trials NSABP-P-1 or NSABP-P-2NCT00967239 · 2009-04-01
UNKNOWNGenetic Susceptibility and Risk of Second Cancers in Patients Who Have Undergone Stem Cell Transplant for CancerNCT00949052 · 2009-01-01
TERMINATEDCancer Genome Study Using Samples From Patients With Stage I or Stage II Non-Small Cell Lung Cancer Treated on Clinical Trial ACOSOG-Z0030NCT00899535 · 2008-10-01
COMPLETEDSorafenib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to ChemotherapyNCT00801385 · 2008-09-01
UNKNOWNStudy of Blood and Tissue Samples From Patients Receiving Androgen Deprivation for Newly Diagnosed Prostate CancerNCT00967954 · 2008-09-01
UNKNOWNLaboratory Study Using Samples From Patients With Non-Small Cell Lung Cancer Treated on Clinical Trial CASE-2507NCT00907699 · 2008-08-01
WITHDRAWNStudying Genes, Environment, and Prostate Cancer Risk in Patients With or Without Prostate CancerNCT01013129 · 2008-07-01
COMPLETEDStudy of Biomarkers in Blood and/or Tumor Tissue Samples From Patients With Ductal Carcinoma in Situ and From Healthy VolunteersNCT00935233 · 2008-07-01
UNKNOWNStudying Breast Cancer Risk in Women Who Are BRCA1/BRCA2 Mutation CarriersNCT00897455 · 2008-04-01
UNKNOWNGenetic Testing in Predicting Biomarkers of Recurrence in Patients With Prostate Cancer Undergoing SurgeryNCT00977457 · 2007-11-26
ACTIVE_NOT_RECRUITINGIodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal CancerNCT00445965 · 2006-01-01
COMPLETEDGenes and Other Risk Factors for Second Primary Breast Cancer in Women With Breast Cancer and Their Female Family Members and FriendsNCT00896818 · 2005-01-01
UNKNOWNStudying Urine and Blood Samples in Women With Newly Diagnosed Breast CancerNCT00766454 · 1998-11-01
COMPLETEDCommon conditions
Breast Cancer9Lung Cancer7Nonneoplastic Condition3Prostate Cancer3Lymphoma2Precancerous Condition2Arterial Hypertension1Brain and Central Nervous System Tumors1brca1 Mutation Carrier1brca2 Mutation Carrier1Cancer1Cervical Cancer1Cognitive Ability, General1Fatigue1Hereditary Prostate Cancer1Intraocular Melanoma1Melanoma (Skin)1Metastatic Cancer1Neuroblastoma1Ovarian Cancer1Pain1Psychosocial Deprivation1Radiation Toxicity1Retinoblastoma1Sarcoma1
Mapped diseases appearing in these trials
Shared study participation does not establish that this intervention treats a disease.
Leading sponsors
AIDS Malignancy Consortium
4
Alliance for Clinical Trials in Oncology
3
Asfendiyarov Kazakh National Medical University
3
Cancer Research UK
2
ECOG-ACRIN Cancer Research Group
2
Wake Forest University Health Sciences
2
Case Comprehensive Cancer Center
1
City of Hope Medical Center
1
Gynecologic Oncology Group
1
Memorial Sloan Kettering Cancer Center
1
NSABP Foundation Inc
1
Portland VA Medical Center
1
Queen Mary University of London
1
Vanderbilt-Ingram Cancer Center
1
Yonsei University
1
Trial status mix
COMPLETED14
UNKNOWN6
TERMINATED3
ACTIVE_NOT_RECRUITING1
WITHDRAWN1
Phase mix
PHASE12
PHASE22
NA1
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.